|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-8-7
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To assess the efficacy and safety of rilonacept (Interleukin-1 [IL-1] Trap), a long-acting and potent inhibitor of IL-1, in patients with cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
pubmed-author:AmarN JNJ,
pubmed-author:BelomestnovPavelP,
pubmed-author:HoffmanHal MHM,
pubmed-author:KavanaughArthurA,
pubmed-author:KivitzAlan JAJ,
pubmed-author:MellisScott JSJ,
pubmed-author:SebaiMohamedM,
pubmed-author:StahlNeilN,
pubmed-author:ThroneMartin LML,
pubmed-author:WeinsteinSteven PSP,
pubmed-author:YancopoulosGeorge DGD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2443-52
|
|
pubmed:dateRevised |
2009-2-5
|
|
pubmed:meshHeading |
pubmed-meshheading:18668535-Adult,
pubmed-meshheading:18668535-Aged,
pubmed-meshheading:18668535-Arthralgia,
pubmed-meshheading:18668535-C-Reactive Protein,
pubmed-meshheading:18668535-Carrier Proteins,
pubmed-meshheading:18668535-Double-Blind Method,
pubmed-meshheading:18668535-Familial Mediterranean Fever,
pubmed-meshheading:18668535-Female,
pubmed-meshheading:18668535-Humans,
pubmed-meshheading:18668535-Immunoglobulin Fc Fragments,
pubmed-meshheading:18668535-Injections, Subcutaneous,
pubmed-meshheading:18668535-Male,
pubmed-meshheading:18668535-Middle Aged,
pubmed-meshheading:18668535-Mutation,
pubmed-meshheading:18668535-Receptors, Interleukin-1,
pubmed-meshheading:18668535-Recombinant Fusion Proteins,
pubmed-meshheading:18668535-Serum Amyloid A Protein,
pubmed-meshheading:18668535-Single-Blind Method,
pubmed-meshheading:18668535-Syndrome,
pubmed-meshheading:18668535-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.
|
|
pubmed:affiliation |
Division of Rheumatology and Allergy/Immunology, University of California at San Diego, La Jolla, CA 92093-0635, USA. hahoffman@popmail.ucsd.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
